Emerging data suggest Retatru tide , a dual stimulator targeting both incretin and glucose-dependent insulinotropic polypeptide , may offer a significant step forward for weight loss . Initial human trials have demonstrated substantial losses in abdominal mass , possibly exceeding existing obesit